Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap.

A 73-year-old woman with Type 1 diabetes and heart disease considers Mounjaro for weight loss, but risks and close monitoring are advised.

Customs agents at O’Hare Airport on Tuesday announced the seizure of a massive shipment of “unapproved medications” from China that included erectile dysfunction and weight loss drugs. The shipment destined for Syracuse, New York, was intercepted by a U.S. Customs and Border Protection team at O’Hare, the agency said i

The FDA issued 25 warning letters to telehealth companies last month over misleading claims about compounded versions of drugs like Ozempic

They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.

A new consensus by leading Indian endocrinologists recommends structured nutritional counselling for every patient taking GLP-1 weight loss drugs such as semaglutide and tirzepatide to preserve muscle and sustain weight loss. (Representative image)Weight loss drugs like semaglutide and tirzepatide have transformed the

Africa · Southern Key Facts —The recall. SAHPRA ordered a Class I, Type A recall of compounded semaglutide and tirzepatide products made by iDexis/Sentra Pharmacy. —The warning. Prescribers and pharmacists face fines from R25,000 to R75,000 (about US$1,500–US$4,600) and potential loss of licence. —The court case. Novo